Aa
A
A
Close
Avatar_universal
Myrcludex B trial response
Thank you very much for your interest to Mircludex B.
You probably know that the drug was developed by the German scientists and phase 1 clinical trial in healthy people has finished in Germany early this year.
Now we are preparing for the next stage of clinical trial to show the drug effect in patients suffering from CHB (without CHD). This will be the first trial in patients. Several hepatology clinics in Russia will participate in. We expect to have the result on the second half next year. Based on it we will correct further development program.


For reference:

Recent update for clinical trial published on 21Sept2012.

The company "Gepatera" Health Ministry received permission to conduct clinical trials
This was written in Russia.

http://maxwellbio.com/ru/news/244
English version:
he company "Gepatera" Health Ministry received permission to conduct clinical trials
September 21, 2012
Cancel
2 Answers
Page 1 of 1
Avatar_universal
Any new update on Myrcludex B trial?
Comment
Cancel
Avatar_universal
Comment
Comment
Submit Comment
Avatar_universal
any update?
Comment
Cancel
Avatar_universal
Comment
Comment
Submit Comment
Your Answer
Avatar_universal
Answer
Know how to answer? Tap here to leave your answer...
Answer
Myrcludex B trial response
Submit Answer
A
A
Blank
Weight Tracker
Weight Tracker
Start Tracking Now
Hepatitis B Community Resources